SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H.G. Haggerty, K.D. Price, J.M. Shenton, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  2. 2
    Anne-Barbara Mongey, Evelyn V. Hess, Systemic Lupus Erythematosus, 2011,

    CrossRef

  3. 3
    H.G. Haggerty, K.D. Price, J.M. Shenton, Comprehensive Toxicology, 2010,

    CrossRef

  4. 4
    Anne-Barbara Mongey, Evelyn V Hess, Drug Insight: autoimmune effects of medications—what's new?, Nature Clinical Practice Rheumatology, 2008, 4, 3, 136

    CrossRef

  5. 5
    Christian Pagnoux, Loïc Guillevin, Digestive Involvement in Systemic Autoimmune Diseases, 2008,

    CrossRef

  6. 6
    Ozge Surmali Onay, Esra Baskin, Figen Ozçay, Engin Melek, Oguz Canan, Banu Bilezikçi, Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient, Rheumatology International, 2007, 27, 9, 869

    CrossRef

  7. 7
    Z. Kuloğlu, A. Kansu, M. Berberoğlu, P. Adıyaman, G. Öcal, N. Girgin, The Incidence and Evolution of Thyroid Dysfunction During Interferon-α Therapy in Children with Chronic Hepatitis Β Infection, Journal of Pediatric Endocrinology and Metabolism, 2007, 20, 2

    CrossRef

  8. 8
    F. Ballanger, M.-L. Allix, M. Rimbert, M. Audrain, J.-Y. Muller, B. Dreno, Auto-immunité induite par l’interféron à faible dose dans le mélanome stade I, Annales de Dermatologie et de Vénéréologie, 2006, 133, 6-7, 543

    CrossRef

  9. 9
    Atsushi INOUE, Shigeki KOIZUMI, Akira MATSUDA, Hitoshi MIZUO, Yoshihiro IRIUDA, Akemi IKOTA, Mutsuo BENIKO, Takashi KOSUGI, Kumiko MATSUYA, Haruhiko KUNITA, Yasuo MASHIO, Graves' Hyperthyroidism Showing Transient Hypothyroidism during Interferon Therapy for Chronic Hepatitis Type C, Endocrine Journal, 2005, 52, 3, 293

    CrossRef

  10. 10
    Roberta Minelli, Maria Antonietta Valli, Clelia Di Seclì, Lorenzo Finardi, Paolo Chiodera, Roberto Bertoni, Carlo Ferrari, Angela Luciana Barilli, Vittorio Coiro, Gloria Saccani Jotti, Roberto Delsignore, Is Steroid Therapy Needed in the Treatment of Destructive Thyrotoxicosis Induced by α-Interferon in Chronic Hepatitis C?, Hormone Research, 2005, 63, 4, 194

    CrossRef

  11. 11
    Cavit Boz, Mehmet Ozmenoglu, Gonulden Aktoz, Sibel Velioglu, Zekeriya Alioglu, Guillain-Barré syndrome during treatment with interferon α for hepatitis B, Journal of Clinical Neuroscience, 2004, 11, 5, 523

    CrossRef

  12. 12
    Anne-Barbara Mongey, Evelyn V. Hess, Systemic Lupus Erythematosus, 2004,

    CrossRef

  13. 13
    E. Verdun, G. Isoardo, A. Oggero, B. Ferrero, A. Ghezzi, E. Montanari, M. Zaffaroni, L. Durelli, Autoantibodies in Multiple Sclerosis Patients Before and During IFN-β1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?, Journal of Interferon & Cytokine Research, 2002, 22, 2, 245

    CrossRef

  14. 14
    T. Papo, Interferon alpha et auto-immunité, La Revue de Médecine Interne, 2002, 23, 501S

    CrossRef

  15. 15
    Doris B. Strader, Understudied populations with hepatitis C, Hepatology, 2002, 36, S1
  16. 16
    Ronald A. Asherson, Mario García-Carrasco, Ma Pilar Brito Zeron, Manuel Ramos-Casals, The Antiphospholipid Syndrome II, 2002,

    CrossRef

  17. 17
    Michael P. Manns, Christian P. Strassburg, Autoimmune hepatitis: Clinical challenges, Gastroenterology, 2001, 120, 6, 1502

    CrossRef

  18. 18
    Anuchit Chutaputti, Adverse effects and other safety aspects of the hepatitis C antivirals, Journal of Gastroenterology and Hepatology, 2000, 15,
  19. 19
    E. P. M. Corssmit, J. de Metz, H. P. Sauerwein, J. A. Romijn, Biologic Responses to IFN-α Administration in Humans, Journal of Interferon & Cytokine Research, 2000, 20, 12, 1039

    CrossRef

  20. 20
    Ronald A. Asherson, Ricard Cervera, Cancer and Autoimmunity, 2000,

    CrossRef

  21. 21
    Orth, Neurath, Schirmacher, Treichel, Meyer zum Büschenfelde, Mayet, Anti-neutrophil cytoplasmic antibodies in a rat model of trinitrobenzenesulphonic acid-induced liver injury, European Journal of Clinical Investigation, 1999, 29, 11
  22. 22
    F.L. Dumoulin, L. Leifeld, T. Sauerbruch, U. Spengler, Autoimmunity induced by interferon-α therapy for chronic viral hepatitis, Biomedicine & Pharmacotherapy, 1999, 53, 5-6, 242

    CrossRef

  23. 23
    MAYET, MÄRKER-HERMANN, SCHLAAK, MEYER ZUM BÜSCHENFELDE, Irregular Cytokine Pattern of CD4+ T Lymphocytes in Response to Staphylococcus aureus in Patients with Wegener's Granulomatosis, Scandinavian Journal of Immunology, 1999, 49, 6
  24. 24
    Roberta Minelli, Lewis E. Braverman, Maria Antonietta Valli, Claudia Schianchi, Mario Pedrazzoni, Franco Fiaccadori, Mario Salvi, Maria Grazia Magotti, Elio Roti, Recombinant interferon α (rIFN-α) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis, Clinical Endocrinology, 1999, 50, 1
  25. 25
    Jean-Charles Duclos-Vallée, Mikio Nishioka, Naoki Hosomi, Keiji Arima, Anne Leclerq, Jean-François Bach, Ana Maria Yamamoto, Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection, Journal of Hepatology, 1998, 28, 6, 965

    CrossRef

  26. 26
    P. Kivisäkk, J. Lundahl, Z. Heigl, S. Fredrikson, No eidence for increased frequency of autoantibodies during interferon-βlb treatment of multiple sclerosis, Acta Neurologica Scandinavica, 1998, 97, 5
  27. 27
    Vincent Leroy, Josiane Arvieux, Marie-Christine Jacob, Marianne Maynard-Muet, Maryline Baud, Jean-Pierre Zarski, Prevalence and significance of anticardiolipin, anti-β2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C, British Journal of Haematology, 1998, 101, 3
  28. 28
    Thomas Orth, Guido Gerken, Roland Kellner, Karl-Hermann Meyer zum Büschenfelde, Werner-Johannes Mayet, Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1, Journal of Hepatology, 1997, 26, 1, 37

    CrossRef

  29. 29
    LEONARD K.H. KOH, FRANCIS S. GREENSPAN, PETER P.B. YEO, Interferon-α Induced Thyroid Dysfunction: Three Clinical Presentations and a Review of the Literature, Thyroid, 1997, 7, 6, 891

    CrossRef

  30. 30
    Jörg Fritzsch, Jürgen Krug, Hans-Jürgen Heberling, Interferontherapie und Autoimmunität, Medizinische Klinik, 1997, 92, 5, 265

    CrossRef

  31. 31
    Thomas Höhler, Guido Gerken, Arman Notghi, Percy Knolle, Roswitha Lubjuhn, Homa Taheri, Peter M. Schneider, Karl-H.Meyer zum Büschenfelde, Christian Rittner, MHC class II genes influence the susceptibility to chronic active hepatitis C, Journal of Hepatology, 1997, 27, 2, 259

    CrossRef

  32. 32
    FRANK SCHUPPERT, ERWIN RAMBUSCH, HARTMUT KIRCHNER, JENS ATZPODIEN, LEONARD D. KOHN, ALEXANDER von zur MÜHLEN, Patients Treated with Interferon-α, Interferon-β, and Interleukin-2 Have a Different Thyroid Autoantibody Pattern Than Patients Suffering from Endogenous Autoimmune Thyroid Disease, Thyroid, 1997, 7, 6, 837

    CrossRef

  33. 33
    Gary L. Davis, TREATMENT OF ACUTE AND CHRONIC HEPATITIS C, Clinics in Liver Disease, 1997, 1, 3, 615

    CrossRef

  34. 34
    Giovanna Fattovich, Giuliano Giustina, Susanna Favarato, Arturo Ruol, A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon, Journal of Hepatology, 1996, 24, 1, 38

    CrossRef

  35. 35
    R.A. Ajjan, P.F. Watson, A.P. Weetman, Cytokines and thyroid function, Advances in Neuroimmunology, 1996, 6, 4, 359

    CrossRef

  36. 36
    P. Falaschi, R. D'Urso, A. Proietti, A. Martocchia, R. Pastore, L. Angelucci, Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis, Life Sciences, 1996, 60, 1, 43

    CrossRef

  37. 37
    Frank Gohlke, Ansgar W. Lohse, Hans P. Dienes, Hanns Löhr, Elisabeth Märker-Hermann, Guido Gerken, Karl-Hermann Meyer zum Büschenfelde, Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis, Journal of Hepatology, 1996, 24, 6, 699

    CrossRef

  38. 38
    Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S. Breanndan Moore, Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis, Journal of Hepatology, 1996, 24, 1, 52

    CrossRef

  39. 39
    Spyros P. Dourakis, Melanie Deutsch, Stephanos J. Hadziyannis, Immune thrombocytopenia and α-interferon therapy, Journal of Hepatology, 1996, 25, 6, 972

    CrossRef

  40. 40
    Jose Luis Calleja, Agustín Albillos, Guillermo Cacho, Jerónimo Iborra, Luis Abreu, Pedro Escartín, Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies, Journal of Hepatology, 1996, 24, 3, 308

    CrossRef

  41. 41
    Enrico Di Cesare, Marcello Previti, Francesco Russo, Santa Brancatelli, Maria Concetta Ingemi, Riccardo Scoglio, Nicola Mazzù, Domenico Cucinotta, Giovanni Raimondo, Interferon-α therapy May induce insulin autoantibody development in patients with chronic viral hepatitis, Digestive Diseases and Sciences, 1996, 41, 8, 1672

    CrossRef

  42. 42
    Elio Roti, Roberta Minelli, Tiziana Giuberti, Silvia Marchelli, Claudia Schianchi, Eliana Gardini, Mario Salvi, Franco Fiaccadori, Giorgio Ugolotti, Tauro M. Neri, Lewis E. Braverman, Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha, The American Journal of Medicine, 1996, 101, 5, 482

    CrossRef

  43. 43
    U. Protzer, H. P. Dienes, L. Bianchi, A. W. Lohse, I. Helmreich-Becker, G. Gerken, K. H. Meyer Büschenfelde, Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis, Liver, 1996, 16, 4
  44. 44
    Kingo Fujimura, Toshiro Takafuta, Shin-ichiro Kuriya, Tsukasa Abe, Jun-ichi Akatsuka, Kojiro Yasunaga, Tatsumi Uchida, Makoto Kawakita, Kiyoshi Kitamura, Takeo Nomura, Atsushi Kuramoto, Recombinant human interferon α-2b (rh IFNα-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP), American Journal of Hematology, 1996, 51, 1
  45. 45
    A.Obaid Shakil, Adrian M. Di Bisceglie, Jay H. Hoofnagle, Seizures during alpha interferon therapy, Journal of Hepatology, 1996, 24, 1, 48

    CrossRef

  46. 46
    Takeshi Okanoue, Shinichi Sakamoto, Yoshito Itoh, Masahito Minami, Koichiro Yasui, Masafumi Sakamoto, Kenichi Nishioji, Tatsuo Katagishi, Yoshihiro Nakagawa, Hisashi Tada, Yoshihiko Sawa, Masayuki Mizuno, Keizo Kagawa, Kei Kashima, Side effects of high-dose interferon therapy for chronic hepatitis C, Journal of Hepatology, 1996, 25, 3, 283

    CrossRef

  47. 47
    Michael W. Fried, THERAPY OF CHRONIC VIRAL HEPATITIS, Medical Clinics of North America, 1996, 80, 5, 957

    CrossRef

  48. 48
    Albert J. Czaja, Autoimmune hepatitis, Digestive Diseases and Sciences, 1995, 40, 2, 435

    CrossRef

  49. 49
    MIAU-JU HUANG, YUN-FAN LIAW, Clinical associations between thyroid and liver diseases, Journal of Gastroenterology and Hepatology, 1995, 10, 3
  50. 50
    B. C. Smith, S. I. Strasser, P. V. Desmond, Current perspectives in hepatitis C, Australian and New Zealand Journal of Medicine, 1995, 25, 4
  51. 51
    Janusz Cianciara, Tomasz Laskus, Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B, Digestive Diseases and Sciences, 1995, 40, 8, 1842

    CrossRef

  52. 52
    Patrick Marcellin, Michèle Pouteau, Jean-Pierre Benhamou, Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction, Journal of Hepatology, 1995, 22, 3, 364

    CrossRef

  53. 53
    Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S.Breanndan Moore, Immunologic features and HLA associations in chronic viral hepatitis, Gastroenterology, 1995, 108, 1, 157

    CrossRef

  54. 54
    Masahide Yoshikawa, Hiroshi Fukui, Tadasu Tsujii, Immunological Adverse Effects of Interferon Treatment, Clinical Immunotherapeutics, 1995, 4, 5, 361

    CrossRef

  55. 55
    Luisa García-Buey, Carmelo García-Monzón, Santiago Rodriguez, María J. Borque, Asunción García-Sánchez, Rosa Iglesias, Mar DeCastro, Fernando G. Mateos, JoséL. Vicario, Antonio Balas, Ricardo Moreno-Otero, Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C, Gastroenterology, 1995, 108, 6, 1770

    CrossRef

  56. 56
    G. M. DUSHEIKO, Management of chronic hepatitis C, Haemophilia, 1995, 1, S4
  57. 57
    Teruo Shiba, Yoshihiro Morino, Kazumi Tagawa, Hitoshi Fujino, Tadao Unuma, Onset of diabetes with high titer anti-GAD antibody after IFN therapy for chronic hepatitis, Diabetes Research and Clinical Practice, 1995, 30, 3, 237

    CrossRef

  58. 58
    Emilio D'Amico, Marino Paroli, Vincenzina Fratelli, Carlo Palazzi, Vincenzo Barnaba, Francesco Callea, Giuseppe Consoli, Primary biliary cirrhosis induced by interferon-α therapy for hepatitis C virus infection, Digestive Diseases and Sciences, 1995, 40, 10, 2113

    CrossRef

  59. 59
    Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S. Breanndan Moore, Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis, Digestive Diseases and Sciences, 1995, 40, 10, 2098

    CrossRef

  60. 60
    TETSUYA MIZOKAMI, KEN OKAMURA, HIROSHI IKENOUE, KAORI SATO, TAKEO KURODA, YOSHIAKI MAEDA, MASATOSHI FUJISHIMA, A High Prevalence of Human T-Lymphotropic Virus Type I Carriers in Patients with Antithyroid Antibodies, Thyroid, 1994, 4, 4, 415

    CrossRef

  61. 61
    Jürgen C. Becker, Barb Winkler, Sabine Klingert, Eva-Bettina Bröcker, Antiphospholipid syndrome associated with immunotherapy for patients with melanoma, Cancer, 1994, 73, 6
  62. 62
    Chronic hepatitis C, Disease-a-Month, 1994, 40, 3, 122

    CrossRef

  63. 63
    Alicia S. Mistchenko, Roberto A. Diez, Ana La Mariani, Julio Robaldo, Alberto F. Maffey, Guillermo Bayley-Bustamante, Sal Grinstein, Cytokines in adenoviral disease in children: Association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome, The Journal of Pediatrics, 1994, 124, 5, 714

    CrossRef

  64. You have free access to this content64
    W.J. MA YET, A. SCHWARTING, K.-H. MEYER ZUM BÜSCHENFELDE, Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells, Clinical & Experimental Immunology, 1994, 97, 3
  65. 65
    Toshinori Kodama, Shigeo Katabami, Keiichi Kamijo, Akio Katanuma, Kentaro Yamashita, Naoki Azuma, Tomohiro Tamaki, Akira Yachi, Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon, Journal of Gastroenterology, 1994, 29, 3, 289

    CrossRef

  66. 66
    Ulrich Treichel, Elisabeth Paietta, Thomas Poralla, Karl-Hermann Meyer zum Büschenfelde, Richard J. Stockert, Effects of cytokines on synthesis and function of the hepatic asialoglycoprotein receptor, Journal of Cellular Physiology, 1994, 158, 3
  67. 67
    Tobias Heintges, T. Frieling, G. Goerz, C. Niederau, Exacerbation of lichen planus but not of acute intermittent hepatic porphyria during interferon therapy in a patient with chronic hepatitis C, Journal of Hepatology, 1994, 21, 6, 1152

    CrossRef

  68. 68
    Paul Weber, Karl-Hermann Wiedmann, Reinhild Klein, Eike Walter, Hubert E. Blum, Peter A. Berg, Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon, Journal of Hepatology, 1994, 20, 3, 321

    CrossRef

  69. 69
    Xiaojian Huang, Bruce Hultgren, Noel Dybdal, Timothy A. Stewart, Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice, Immunity, 1994, 1, 6, 469

    CrossRef

  70. 70
    M. Chigira, Self and nonself: Duality of immune system, Medical Hypotheses, 1994, 43, 1, 6

    CrossRef

  71. 71
    A. S. F. Lok, Treatment of chronic hepatitis B, Journal of Viral Hepatitis, 1994, 1, 2
  72. 72
    Anna S. F. Lok, Michael A. Gerber, A young woman with chronic hepatitis, Hepatology, 1993, 17, 4
  73. 73
    Michel Warny, Reginald Brenard, Chantal Cornu, Jean-Paul Tomasi, André-Pierre Geubel, Anti-neutrophil antibodies in chronic hepatitis and the effect of α-interferon therapy, Journal of Hepatology, 1993, 17, 3, 294

    CrossRef

  74. You have free access to this content74
    W.-J. MAYET, K.-H. MEYER ZUM BÜSCHENFELDE, Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells, Clinical & Experimental Immunology, 1993, 94, 3
  75. 75
    Robert P. Perrillo, Antiviral therapy of chronic hepatitis B: past, present, and future, Journal of Hepatology, 1993, 17, S56

    CrossRef

  76. 76
    U. Treichel, G. Gerken, S. Rossol, H.W. Rotthauwe, K.-H. Meyer zum Büschenfelde, T. Poralla, Autoantibodies against the human asialoglycoprotein receptor: Effects of therapy in autoimmune and virus-induced chronic active hepatitis, Journal of Hepatology, 1993, 19, 1, 55

    CrossRef

  77. 77
    M. Yoshikawa, T. Sakamoto, A. MitorO, T. Mochi, H. Tsujii, M. Koizumi, H. Yoshiji, Y. Sakaguchi, H. Fukui, H. Nakano, T. Tsujii, Autoimmunity during alpha-interferon therapy for chronic hepatitis C, Gastroenterologia Japonica, 1993, 28, S5, 109

    CrossRef

  78. 78
    Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S. Breanndan Moore, Howard F. Taswell, Henry A. Homburger, Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States, Journal of Hepatology, 1993, 18, 3, 342

    CrossRef

  79. 79
    Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S. Breanndan Moore, Genetic predispositions for the immunological features of chronic active hepatitis, Hepatology, 1993, 18, 4
  80. 80
    L. D'Hondt, A. Delannoy, C. Docquier, Hypothyroidism and arthritis during interferon therapy, Clinical Rheumatology, 1993, 12, 3, 415

    CrossRef

  81. 81
    Robert P. Perrillo, Interferon in the management of chronic hepatitis B, Digestive Diseases and Sciences, 1993, 38, 4, 577

    CrossRef

  82. 82
    D. Pateron, D.J. Hartmann, J.C. Duclos-Vallée, H. Jouanolle, M. Beaugrand, Latent autoimmune thyroid disease in patients with chronic HCV hepatitis, Journal of Hepatology, 1993, 17, 3, 417

    CrossRef

  83. 83
    Luigi Muratori, Daniela Zauli, Fabrizio Giostra, Giorgio Ballardini, Marco Lenzi, Fabio Cassani, Francesco B. Bianchi, LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment, Journal of Hepatology, 1993, 18, 2, 259

    CrossRef

  84. 84
    J. Dupont, J. Orgiazzi, A. Burger, Maladies auto-immunes et traitement par l'IFN-α: revue de la littérature à propos d'un cas d'hyperthyroïdie, La Revue de Médecine Interne, 1993, 14, 2, 93

    CrossRef

  85. 85
    P. Fabris, A. Floreani, F.De Lazzari, C. Betterle, N.A. Greggio, R. Naccarato, M. Chiaramonte, Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis, The Lancet, 1992, 340, 8818, 548

    CrossRef

  86. 86
    D. Pateron, D.J. Hartmann, J.C. Duclos-Vallee, H. Jouanolle, M. Beaugrand, Latent autoimmune thyroid disease in patients with chronic HCV hepatitis, Journal of Hepatology, 1992, 16, 1-2, 244

    CrossRef

  87. 87
    Leonard D. Kohn, Shinji Kosugi, Toshiaki Ban, Motoyasu Saji, Shoichiro Ikuyama, Cesidio Giuliani, Akinari Hidaka, Hiroki Shimura, Takashi Akamizu, Kazuo Tahara, John Moriarty, Bellur S. Prabhakar, Dinah S. Singer, Molecular Basis for the Autoreactivity Against Thyroid Stimulating Hormone Receptor, International Reviews of Immunology, 1992, 9, 2, 135

    CrossRef

  88. 88
    G. C. B. CHAN, S. S. LEE, E. K. YEOH, Mono-arthritis in a chronic hepatitis B patient after α-interferon treatment, Journal of Gastroenterology and Hepatology, 1992, 7, 4
  89. You have free access to this content89
    H. GISSLINGER, B. GILLY, W. WOLOSZCZUK, W.R. MAYR, L. HAVELEC, W. LINKESCH, M. WEISSEL, Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha, Clinical & Experimental Immunology, 1992, 90, 3
  90. 90
    S. Maccari, C. Bassi, A. G. Giovannini, A. C. Plancher, A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy, Clinical Rheumatology, 1991, 10, 4, 452

    CrossRef

  91. 91
    G. M. DUSHEIKO, Alpha-interferon treatment of chronic hepatitis B infection: Predictors of responsiveness, Journal of Gastroenterology and Hepatology, 1991, 6, S1
  92. 92
    G. Fattovich, C. Betterle, L. Brollo, B. Pedini, G. Giustina, G. Realdi, A. Alberti, A. Ruol, Autoantibodies during α-interferon therapy for chronic hepatitis B, Journal of Medical Virology, 1991, 34, 2
  93. 93
    Gary L. Davis, Hepatitis C Virus Antibody in Patients With Chronic Autoimmune Hepatitis: Pitfalls in Diagnosis and Implications for Treatment, Mayo Clinic Proceedings, 1991, 66, 6, 647

    CrossRef

  94. You have free access to this content94
    Y. IKEDA, G. TODA, N. HASHIMOTO, N. UMEDA, K. MIYAKE, M. YAMANAKA, K. KUROKOWA, Naturally occurring anti-interferon-α2a antibodies in patients with acute viral hepatitis, Clinical & Experimental Immunology, 1991, 85, 1
  95. 95
    Adrian M. Di Bisceglie, Jay H. Hoofnagle, Therapy of chronic hepatitis C with α-interferon: The answer? Or more questions?, Hepatology, 1991, 13, 3
  96. 96
    Douglas J. Schwartzentruber, Donald E. White, Mark H. Zweig, Bruce D. Weintraub, Steven A. Rosenberg, Thyroid dysfunction associated with immunotherapy for patients with cancer, Cancer, 1991, 68, 11
  97. 97
    GEOFFREY C. FARRELL, Treatment of chronic hepatitis C with alpha-interferon, Journal of Gastroenterology and Hepatology, 1991, 6, S1
  98. 98
    Juhana E. Idänpään-Heikkilä, Kari Aranko, 1991,

    CrossRef

  99. 99
    G. Saracco, A. Touscoz, M. Durazzo, F. Rosina, E. Donegani, L. Chiandussi, V. Gallo, R. Petrino, A.G. De Micheli, A. Solinas, A. Deplano, A. Tocco, P.A. Cossu, C. Pintus, G. Verme, M. Rizzetto, Autoantibodies and response to α-interferon in patients with chronic viral hepatitis, Journal of Hepatology, 1990, 11, 3, 339

    CrossRef

  100. 100
    W. -J. Mayet, E. Hermann, M. Bachmann, M. Manns, K. -H. Meyer zum Büschenfelde, Correlation of anti-cytoskeleton antibody activities in synovial fluid with interleukin-6 in patients with osteoarthritis and inflammatory joint disease, Klinische Wochenschrift, 1990, 68, 13, 685

    CrossRef

  101. 101
    O. Weiland, R. Schvarcz, R. Wejstål, G. Norkrans, A. Frydén, Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience, Journal of Hepatology, 1990, 11, S57

    CrossRef

  102. 102
    Sandro Vento, Giovanni Di Perri, Roberto Luzzati, Tiziana Garofano, Ercole Concia, Dante Bassetti, Type 2 autoimmune hepatitis and hepatitis C virus infection, The Lancet, 1990, 335, 8694, 921

    CrossRef

  103. 103
    J.H. Hoofnagle, α-Interferon therapy of chronic hepatitis B. Current status and recommendations, Journal of Hepatology, 1990, 11, S100

    CrossRef

  104. 104
    Robert Schvarcz, Ola Weiland, Rune Wejstal, Gunnar Norkrans, Aril Fryden, Ulla Foberg, A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus Antibodies, Scandinavian Journal of Infectious Diseases, 1989, 21, 6, 617

    CrossRef